Vascular targeting therapy: potential benefit depends on tumor and host related effects.

作者: Horsman Mr , Bohn Ab , Busk M

DOI:

关键词:

摘要: [1]. With an adequate blood supply unrestricted growth of the primary tumor and metastatic spread can occur. The vasculature that develops arises from pre-existing normal host by process angiogenesis [2]. In adults, is normally only associated with certain physiological processes including female reproductive cycle, pregnancy, muscular hypertrophy wound healing [3]. How-ever, it seen a number pathological condi-tions, rheumatoid arthritis, diabetes, macular degeneration, psoriasis, cardiovascular disease course cancer actual triggers initiate are not fully established. Hypoxia clearly one factor plays significant role [4], but other «non-hypoxia factors» have also been implicated loss suppressor gene function oncogene activation [4, 5]. Once triggered, angio-genic starts release angiogenic factors, primarily vascular endothelial (VEGF), cells [6]. These factors then set in motion cascade events include enzymatic destruction basal membrane cells, migration into extracellu-lar matrix to form sprouts, cell division away sprout tip [7]. Solid strands endothe-lial formed extracellular matrix, lumen within those strands, neighbouring sprouts fuse loops, loops new buds emerge Functional vessels finally established (Fig. 1).

参考文章(40)
Simon Tazzyman, Claire E. Lewis, Craig Murdoch, Neutrophils: key mediators of tumour angiogenesis International Journal of Experimental Pathology. ,vol. 90, pp. 222- 231 ,(2009) , 10.1111/J.1365-2613.2009.00641.X
Henry Brem, Arnall Patz, Daniel Finkelstein, Judah Folkman, Steven Brem, Prolonged Tumor Dormancy by Prevention of Neovascularization in the Vitreous Cancer Research. ,vol. 36, pp. 2807- 2812 ,(1976)
Friedrich Kallinowski, Paul Okunieff, Peter Vaupel, Blood Flow, Oxygen and Nutrient Supply, and Metabolic Microenvironment of Human Tumors: A Review Cancer Research. ,vol. 49, pp. 6449- 6465 ,(1989)
Gillian M. Tozer, Chryso Kanthou, Bruce C. Baguley, Disrupting tumour blood vessels Nature Reviews Cancer. ,vol. 5, pp. 423- 435 ,(2005) , 10.1038/NRC1628
Victoria L. Heath, Roy Bicknell, Anticancer strategies involving the vasculature Nature Reviews Clinical Oncology. ,vol. 6, pp. 395- 404 ,(2009) , 10.1038/NRCLINONC.2009.52
Qingen Ke, Natalya Bodyak, Debra L. Rigor, Nicole W. Hurst, David J. Chaplin, Peter M. Kang, Pharmacological inhibition of the hypertensive response to combretastatin A-4 phosphate in rats. Vascular Pharmacology. ,vol. 51, pp. 337- 343 ,(2009) , 10.1016/J.VPH.2009.08.004
Dietmar W. Siemann, Kenneth H. Warrington, Michael R. Horsman, Targeting tumor blood vessels: an adjuvant strategy for radiation therapy. Radiotherapy and Oncology. ,vol. 57, pp. 5- 12 ,(2000) , 10.1016/S0167-8140(00)00243-7
Alberto Mantovani, Tiziana Schioppa, Chiara Porta, Paola Allavena, Antonio Sica, Role of tumor-associated macrophages in tumor progression and invasion. Cancer and Metastasis Reviews. ,vol. 25, pp. 315- 322 ,(2006) , 10.1007/S10555-006-9001-7
Peter Carmeliet, Angiogenesis in health and disease. Nature Medicine. ,vol. 9, pp. 653- 660 ,(2003) , 10.1038/NM0603-653